Collectively, our findings illuminate the Inhba/Smad2/E2f4 axis as a central driver of TCs proliferation in PCOS and underscore its potential as a target for developing molecular therapies aimed at addressing the underlying pathophysiology of this complex disorder. The gene discussed is E2F4; the disease is polycystic ovary syndrome.